BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,832,767 | -31.6% | 48,563 | -17.5% | 0.01% | -30.0% |
| Q2 2023 | $2,680,248 | -5.8% | 58,829 | -16.1% | 0.02% | -9.1% |
| Q1 2023 | $2,845,242 | -84.5% | 70,149 | -80.5% | 0.02% | -85.2% |
| Q4 2022 | $18,346,294 | -23.0% | 359,943 | -18.6% | 0.15% | -28.0% |
| Q3 2022 | $23,827,000 | -42.3% | 442,394 | -31.1% | 0.21% | -38.4% |
| Q2 2022 | $41,263,000 | -20.3% | 642,417 | -3.8% | 0.34% | -5.4% |
| Q1 2022 | $51,788,000 | -2.1% | 667,887 | +8.4% | 0.36% | +2.6% |
| Q4 2021 | $52,882,000 | +44.0% | 616,057 | +35.0% | 0.35% | +33.1% |
| Q3 2021 | $36,717,000 | +925.9% | 456,505 | +926.9% | 0.26% | +940.0% |
| Q2 2021 | $3,579,000 | -2.1% | 44,456 | +2.5% | 0.02% | -10.7% |
| Q1 2021 | $3,657,000 | -11.5% | 43,364 | -15.8% | 0.03% | -15.2% |
| Q4 2020 | $4,133,000 | -3.5% | 51,506 | -3.3% | 0.03% | -15.4% |
| Q3 2020 | $4,282,000 | -16.1% | 53,239 | -10.2% | 0.04% | -22.0% |
| Q2 2020 | $5,105,000 | +2.8% | 59,291 | -3.0% | 0.05% | -16.7% |
| Q1 2020 | $4,964,000 | -1.5% | 61,140 | +1.5% | 0.06% | +25.0% |
| Q4 2019 | $5,038,000 | -8.5% | 60,251 | -4.3% | 0.05% | -15.8% |
| Q3 2019 | $5,509,000 | +7.6% | 62,980 | +0.8% | 0.06% | 0.0% |
| Q2 2019 | $5,120,000 | +2.7% | 62,511 | +2.0% | 0.06% | -3.4% |
| Q1 2019 | $4,984,000 | +21.1% | 61,295 | -1.9% | 0.06% | +13.5% |
| Q4 2018 | $4,114,000 | -12.2% | 62,490 | +2.8% | 0.05% | -7.1% |
| Q3 2018 | $4,685,000 | +6.8% | 60,768 | +2.3% | 0.06% | 0.0% |
| Q2 2018 | $4,388,000 | -42.7% | 59,414 | -49.6% | 0.06% | +9.8% |
| Q1 2018 | $7,664,000 | +94.7% | 117,826 | +93.5% | 0.05% | 0.0% |
| Q4 2017 | $3,937,000 | -1.4% | 60,902 | -4.3% | 0.05% | -5.6% |
| Q3 2017 | $3,993,000 | +47.4% | 63,630 | +42.2% | 0.05% | +42.1% |
| Q2 2017 | $2,709,000 | +12.8% | 44,751 | -3.3% | 0.04% | +11.8% |
| Q1 2017 | $2,401,000 | +26.1% | 46,290 | +7.8% | 0.03% | +21.4% |
| Q4 2016 | $1,904,000 | +0.2% | 42,951 | +7.5% | 0.03% | -6.7% |
| Q3 2016 | $1,901,000 | +3.0% | 39,950 | -2.1% | 0.03% | +3.4% |
| Q2 2016 | $1,846,000 | -14.4% | 40,817 | -22.2% | 0.03% | -19.4% |
| Q1 2016 | $2,157,000 | +6.4% | 52,490 | -1.2% | 0.04% | +5.9% |
| Q4 2015 | $2,027,000 | -1.9% | 53,129 | -15.6% | 0.03% | -5.6% |
| Q3 2015 | $2,067,000 | -62.4% | 62,935 | -19.9% | 0.04% | -58.1% |
| Q2 2015 | $5,498,000 | -18.9% | 78,619 | -20.6% | 0.09% | -18.1% |
| Q1 2015 | $6,783,000 | -4.8% | 99,024 | +1.9% | 0.10% | -7.1% |
| Q4 2014 | $7,124,000 | +27.6% | 97,201 | +24.9% | 0.11% | +22.8% |
| Q3 2014 | $5,585,000 | -4.6% | 77,815 | -3.9% | 0.09% | -4.2% |
| Q2 2014 | $5,854,000 | -6.9% | 80,971 | -5.3% | 0.10% | -10.3% |
| Q1 2014 | $6,290,000 | -48.3% | 85,485 | -51.2% | 0.11% | -49.3% |
| Q4 2013 | $12,175,000 | -17.4% | 175,056 | -22.0% | 0.21% | -20.7% |
| Q3 2013 | $14,746,000 | +150.7% | 224,487 | +164.4% | 0.27% | +144.0% |
| Q2 2013 | $5,882,000 | +108.5% | 84,906 | +118.6% | 0.11% | +98.2% |
| Q1 2013 | $2,821,000 | – | 38,836 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |